Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medivation Inc (MDVN)

Medivation Inc (MDVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,514,170
  • Shares Outstanding, K 165,010
  • Annual Sales, $ 943,260 K
  • Annual Income, $ 244,730 K
  • 60-Month Beta 0.60
  • Price/Sales 14.33
  • Price/Cash Flow 104.20
  • Price/Book 25.18
Trade MDVN with:
  • Price/Earnings ttm 105.74
  • Earnings Per Share ttm 0.77
  • Most Recent Earnings $0.29 on 08/09/16
  • Latest Earnings Date 11/03/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/16
See More
  • Average Estimate 0.30
  • Number of Estimates 4
  • High Estimate 0.33
  • Low Estimate 0.25
  • Prior Year 0.27
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.25 +1.53%
on 08/30/16
81.48 unch
on 09/28/16
+1.13 (+1.41%)
since 08/26/16
3-Month
58.80 +38.57%
on 07/05/16
81.48 unch
on 09/28/16
+23.69 (+40.99%)
since 06/28/16
52-Week
26.41 +208.52%
on 02/09/16
81.48 unch
on 09/28/16
+41.65 (+104.57%)
since 09/28/15

Most Recent Stories

More News
Analysts Holding As Pfizer Waits On Two Phase 3 Studies

Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.

PFE : 27.72 (-0.79%)
MDVN : 81.48 (+0.05%)
AZN : 65.85 (-0.69%)
CLVS : 0.0812 (-5.58%)
TSRO : 74.96 (+0.03%)
BHVN : 56.74 (-0.58%)

Business Summary

Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current portfolio consists of small molecule drugs in development to treat three large, unmet medical needs Alzheimer's...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 81.50
1st Resistance Point 81.47
Last Price 81.48
1st Support Level 81.42
2nd Support Level 81.40
3rd Support Level N/A

See More

52-Week High 81.48
Last Price 81.48
Fibonacci 61.8% 60.44
Fibonacci 50% 53.94
Fibonacci 38.2% 47.45
52-Week Low 26.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar